Evidence map›Paper›PMID 41243978›Full record

ArticleNucleic acids research2026

Therapeutic target database 2026: facilitating targeted therapies and precision medicine.

Yintao Zhang, Ying Zhou, Hangwei Xu, Wanghao Jiang, Bo Li, Dianyu Lai, Cong Wan, Shanshan Wang, Mingxiao Zhao, Ying Tan and 5 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Protective role ofFrontiers in pharmacology · 2026
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yintao ZhangCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-5263-3438
Ying ZhouDepartment of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.ORCID 0009-0007-3875-3496
Hangwei XuCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
Wanghao JiangCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
Bo LiWisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
Dianyu LaiChu Kochen Honors College, Zhejiang University, Hangzhou 310058, China.
Cong WanSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Shanshan WangQian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China.
Mingxiao ZhaoQian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China.
Ying TanState Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China.
Songlin LuInstitute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518000, China.ORCID 0000-0003-1440-3938
Tingting FanInstitute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518000, China.
Xin LiuWisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.ORCID 0000-0002-6542-3181
Feng ZhuCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-8069-0053
Yuzong ChenInstitute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518000, China.ORCID 0000-0002-5473-8022

Funding

National Key R&D Program of People's Republic of China 2024YFA1307503National Natural Science Funding of China 22220102001National Natural Science Funding of China 62502424National Natural Science Funding of China 82373790Natural Science Foundations of Zhejiang RG25H300001Postdoctoral Fellowship Program of CPSF GZC20252382Zhejiang University
6 · The paper itself

Abstract

Development of targeted therapeutics begins with the discovery and validation of therapeutic targets, which builds the foundation for rational drug design. Extensive information on target-disease associations, target perturbation profiles, drug bioactivity landscapes, and clinical profiles is critical for identifying disease-relevant targets, elucidating their biological functions, and assessing the therapeutic potential. Therapeutic target database 2026 represents a major update that expands multiple layers of data essential for drug discovery. Key expansions include (i) 306 247 target-disease associations covering 2912 targets, (ii) 10 506 perturbation profiles triggered by genetic modification or chemical interference on 2368 targets, (iii) multidimensional activity landscapes of 17 806 drugs, encompassing cytotoxic, antimicrobial-, and molecular-level activities, and (iv) abundant clinical profiles for 2234 approved drugs. As a result, this update provides expanded and curated information on 3798 targets and 40 398 drugs. To enhance usability and scalability, the database framework has been rebuilt, which can be freely accessible without any login requirement at https://idrblab.org/ttd/.

Indexed as

Databases, FactualDatabases, PharmaceuticalDrug DiscoveryMolecular Targeted TherapyPrecision MedicineHumans

Identifiers

PMID41243978
PMCPMC12807707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.